Lynac-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the reduction of inflammation and edema by breaking down inflammatory mediators and promoting the drainage of inflammatory exudates. The synergistic action of these three components makes Lynac-SP Tablet suitable for managing acute musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries. It is particularly beneficial in conditions where both pain relief and reduction of inflammation and swelling are desired. The combination improves patient compliance by minimizing the need for multiple medications. Lynac-SP should be used under medical supervision, with caution advised in patients with a history of gastrointestinal ulcers, bleeding disorders, or hepatic and renal impairment. Common side effects may include gastrointestinal discomfort, nausea, and allergic reactions.